Skip to content

Clinical trials

Psychotic Disorders trials in Portugal

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Psychotic Disorders Country / region: Portugal Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20043
20211
20231
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Recruiting3
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
CEDIARA - Assoc. Solidariedade Social de Ribeira de Fráguas1
Eli Lilly and Company1
Janssen-Cilag International NV1
Karuna Therapeutics, Inc., a Bristol Myers Squibb company1
Lisbon Institute of Global Mental Health - LIGMH1
MapLight Therapeutics1
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.1
University of Trás-os-Montes and Alto Douro1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Psychotic Disorders8
Schizophrenia5
Mental Disorders3
Alzheimer Disease2
Bipolar Disorder1
Brain Diseases1
Central Nervous System Diseases1
Dementia1
Hallucinations1
Nervous System Diseases1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.